Army Picks Battelle to Develop Vaccines for Biological, Chemical Threats Under $59M Contract
Battelle has received a potential five-year, $59 million contract from the U.S. Army to conduct research and develop therapeutics and vaccines for chemical and biological threats. The Army’s joint program executive office for chemical and biological defense awarded the contract through the General Services Administration‘s One Acquisition Solution for Integrated Services contract vehicle, Battelle said Monday. Battelle […] More